Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1419 | GSK2334470 | 10.0 | 0.4604 | 0.01773 |
| HCC1419 | Ribociclib | 0.001 | 0.9093 | 0.00198 |
| HCC1419 | Ribociclib | 0.001 | 0.9875 | -0.00320 |
| HCC1419 | Ribociclib | 0.001 | 0.9200 | -0.00416 |
| HCC1419 | Ribociclib | 0.00316227766017 | 0.8085 | -0.00390 |
| HCC1419 | Ribociclib | 0.00316227766017 | 1.0641 | -0.00632 |
| HCC1419 | Ribociclib | 0.00316227766017 | 0.7040 | 0.00266 |
| HCC1419 | Ribociclib | 0.01 | 0.8166 | -0.00221 |
| HCC1419 | Ribociclib | 0.01 | 0.7808 | 0.00246 |
| HCC1419 | Ribociclib | 0.01 | 0.7354 | -0.00098 |
| HCC1419 | Ribociclib | 0.0316227766017 | 0.8736 | -0.00639 |
| HCC1419 | Ribociclib | 0.0316227766017 | 0.8987 | 0.00120 |
| HCC1419 | Ribociclib | 0.0316227766017 | 0.8452 | 0.00474 |
| HCC1419 | Ribociclib | 0.1 | 0.6597 | 0.00811 |
| HCC1419 | Ribociclib | 0.1 | 0.5073 | 0.01241 |
| HCC1419 | Ribociclib | 0.1 | 0.7365 | 0.01069 |
| HCC1419 | Ribociclib | 0.316227766017 | 0.5622 | 0.00760 |
| HCC1419 | Ribociclib | 0.316227766017 | 0.5855 | 0.00459 |
| HCC1419 | Ribociclib | 0.316227766017 | 0.4992 | 0.02015 |
| HCC1419 | Ribociclib | 1.0 | 0.6289 | 0.00747 |
| HCC1419 | Ribociclib | 1.0 | 0.6602 | 0.00561 |
| HCC1419 | Ribociclib | 1.0 | 0.5979 | 0.00724 |
| HCC1419 | Ribociclib | 3.16227766017 | 0.4784 | 0.00642 |
| HCC1419 | Ribociclib | 3.16227766017 | 0.5588 | 0.01262 |
| HCC1419 | Ribociclib | 3.16227766017 | 0.5844 | 0.00727 |